We help secure non-dilutive funding for R&D activities
June 27, 2013/by Ayal RonenTurning Non-Dilutive Funding into a Strategic Source of Funding
June 27, 2013/by Ayal RonenAttending to the Interests and Needs of the Bio Defense Community
June 27, 2013/by Ayal RonenSBIR/STTR & Beyond – Common Misperceptions
June 27, 2013/by Ayal RonenLast Minute Applications
June 27, 2013/by Ayal RonenPart 2:Turning non-dilutive funding into a strategic source of funding for the life science industry
June 27, 2013/by Ayal RonenPart 1:Turning non-dilutive funding into a strategic source of funding for the life science industry
June 27, 2013/by Ayal RonenThe Path to Large Scale Funding Opportunities
June 27, 2013/by Ayal RonenPart 2: Non-dilutive Funding Forecast 2013
June 27, 2013/by Ayal RonenJoin the FreeMind Network – Become our Partner!
June 27, 2013/by Ayal RonenA Strategic Source of Funding from Basic Research to Clinical Trials
June 27, 2013/by Ayal RonenPart 1: Non-dilutive Funding Forecast 2013
June 26, 2013/by omerSearch
Recent Posts
BioFuture, October 27-28, 2026, NYCAugust 2, 2026 - 6:59 am
RESI Boston, September 22-23, 2026, Boston, USAJuly 30, 2026 - 8:42 am
LSX USA Congress, September 23-24, 2026, Boston, USAJuly 30, 2026 - 8:37 am
The 2026 Mid-Year Non-Dilutive Funding Landscape ReportJuly 20, 2026 - 9:44 am
SBIR Is Back — Here’s What Changed and What You Need to Do NowJune 16, 2026 - 8:03 am
